BSMO
1.2.2021 01:32:14 CET | Business Wire | Press release
BSMO Co., Ltd. (Headquarters: Minato-ku, Tokyo, Representative Director: Tadashi Shimizu, hereinafter "BSMO") has announced today that BSMO has entered into a business alliance agreement with SBI Africa Co., Ltd. (Headquarters: Minato-ku, Tokyo, Representative Director: Tomoya Kitagawa, hereinafter "SBI Africa").
1. Background
As a pioneer in the field of SNS marketing, BSMO, through the best use of D2C x SNS marketing expertise and technology, provides one-stop growth hacking services for D2C e-commerce companies and helps deliver high-quality Japanese products and services to the world.
The population of Africa, where many emerging countries are located, is expected to double from 1.06 billion in 2019 to 2.11 billion people in 2050, according to the latest United Nations projections.
With the rapid population growth and economic growth in the African countries, the automobile usage rate is increasing every year which is driving a strong demand for reliable and affordable used cars from Japan.
By forming a business alliance with SBI Africa, which exports Japanese used cars to emerging countries, BSMO will introduce its D2C x SNS marketing expertise and technology to the SBI Group in order to strengthen the D2C exports in Africa, and thus improve the profitability and corporate values of both parties.
2. Details of the Business Alliance
(1) Improving the quality of SBI Africa's products and services by providing marketing research, advertising strategies, measurement strategies, design strategies, AI analytics, operations services and customer support services.
(2) Improving the profitability and brand value of both parties in the African region through joint sales of BSMO affiliated products and services on SBI Africa’s cross-border e-commerce website.
(3) Jointly providing system development and marketing strategy services for Japanese companies operating in Africa.
(4) Improving the profitability of BSMO and the marketing capabilities of SBI Group, through BSMO’s introduction of its marketing expertise and technology to SBI Group, etc.
[Company Overview]
Name |
BSMO Co., Ltd. |
Location |
1-17-1 Toranomon, Minato-ku, Tokyo Toranomon Hills Business Tower 14th floor |
Representative |
Tadashi Shimizu |
Business Description |
D2C marketing business, global growth hack business using SNS, branding business, media business, system development business, artificial intelligence (AI) development business, etc. |
Name |
SBI Africa Co., Ltd. |
Location |
1-6-1 Roppongi, Minato-ku, Tokyo Izumi Garden Tower 15F |
Representative |
Tomoya Kitagawa |
Business Description |
Overseas export business of domestic used cars, financial service provision business in partnership with overseas financial institutions, venture capital investment targeting the African region, etc. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210131005005/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release
Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release
Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
